Form 144 - Report of proposed sale of securities:
SEC Accession No. 0002007317-25-000115
Filing Date
2025-02-10
Accepted
2025-02-10 17:24:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2895
  Complete submission text file 0002007317-25-000115.txt   4343
Mailing Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036
Business Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036 503-299-1150
Schrodinger, Inc. (Subject) CIK: 0001490978 (see all company filings)

EIN.: 954284541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39206 | Film No.: 25606760
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address SCHRODINGER, INC. 120 WEST 45TH STREET, 17TH FLOOR NEW YORK NY 10036
Business Address
Abel Robert Lorne (Reporting) CIK: 0001798179 (see all company filings)

Type: 144